Cubicin (daptomycin for injection)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   July 2016 ADVERSE REACTIONS Post-Marketing Experience Addition of the following adverse reactions: Blood and...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts